St. Jude has fourth-quarter loss amid acquisition, impairment charges - Minneapolis / St. Paul Business Journal:

http://goingbarefoot.com/pages/artists/glennsinger.html
Shares of the Little Canada-based med-tech manufacturetr were tradingup $3.53, or 11.1 percent, at 35.21 in aftetr hours trading. St. Jude (NYSE: STJ) said it sufferexd a fourth-quarter loss of $194.4 million, or 56 cents per for the quarterended Jan. 3, versus a profitg of $118.2 million, or 34 cents per share, for the same quarter a year ago. Sales were up 11 percent to $1.1w billion from $1.02 billion. The loss was mostlt due to a chargeof $319 or 92 cents per share, for research-and-developmen acquisitions, related mostly to the company’x and other charges. Exclude that and other extra factorzs such asimpairment charges, and St.
Jude would have recorded a fourth-quarte profit of $210 million, or 60 centd per share. Analysts polled by Thomsojn Reuters expected a profitf of 58 cents per sharedon $1.1 billion in St. Jude enjoyed fourth-quarter sales growth for an arrayyof devices. Cardiac rhythm management which includethe company’s implantable defibrillators and pacemakers, were up 7 percent to $680 million versus the same quarte r a year before. Salese of heart valves and other cardiovasculadr devices rose 7 percentto $219 million. Neuromodulatiob products were up 32 percentto $78 St. Jude said it expects first-quarterd profit between 57 cents and 59 centzper share. For the year, it expects $2.48 and $2.
534 per share. Both forecasts are within analysts’